Concizumab ,Alhemo ,TFPI ,Monoclonal Antibody ,CAS No.1312299-39-0
Concizumab ,Alhemo ,TFPI ,Monoclonal Antibody ,CAS No.1312299-39-0
Trade Name
Alhemo
Target
TFPI
Molecular Type
Monoclonal Antibody
Sales In 2025 (Millions Of USD)
200~500(estimate)
Product Description
Detailed Specifications & Features
Trade Name : Alhemo
Target : TFPI
Molecular Type : Monoclonal Antibody
Sales in 2025 (Millions of USD) : 200~500(estimate)
All detailed product information shall be subject to the issued final COA.
Should you need further in-depth documentation for this item, kindly get in touch with us.
